October 24, 2011
Expediting FDA Review: Good for Corporations; Bad for Consumers
Last week, the Senate proposed a bill purporting to accelerate the FDA’s review times for medical devices. The proposed legislation would relax current conflict of interest rules that apply to FDA advisers, reversing an